ImmunityBio (STU:26CA) Dividends per Share: €0.00 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:26CA ImmunityBio Inc STU:26CA
64 GF Score
Price €7.25
GF Value €19.60
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is ImmunityBio Dividends per Share?

ImmunityBio STU:26CA +2.55% 64 Dividends per Share is €0.00 as of Jun. 2026. GuruFocus rates STU:26CA with a GF Score™ of 64/100 and a GF Value™ of €19.60 (Possible Value Trap). The stock has 5 warning signs investors should review.

ImmunityBio's dividends per share for the three months ended in Jun. 2026 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2026 was €0.00. Its Dividend Payout Ratio for the three months ended in Jun. 2026 was 0.00. As of today, ImmunityBio's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

ImmunityBio  (STU:26CA) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

ImmunityBio's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=0/ -0.154
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunityBio Dividends per Share Related Terms

ImmunityBio Dividends per Share Historical Data

* Premium members only.

The historical data trend for ImmunityBio's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunityBio Dividends per Share Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividends per Share
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ImmunityBio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:26CA vs RYTM, PCVX, MIRM: Dividends per Share Comparison

For the Biotechnology subindustry, ImmunityBio's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunityBio Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunityBio's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ImmunityBio's Dividend Yield % falls into.


STU:26CA
64GF Score
ImmunityBio Inc STU:26CA
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ImmunityBio Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of €0.00 mean?
ImmunityBio (STU:26CA) has a Dividends per Share of €0.00 as of Jun. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on ImmunityBio and its competitors.
Is ImmunityBio's Dividends per Share too high?
ImmunityBio's current Dividends per Share is €0.00. Overall, ImmunityBio has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ImmunityBio's Dividends per Share compare to RYTM and PCVX?
ImmunityBio's Dividends per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on ImmunityBio and its competitors. ImmunityBio's current Dividends per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ImmunityBio stock overvalued right now?
Based on GuruFocus' analysis, ImmunityBio (STU:26CA) is currently considered Possible Value Trap. The stock's GF Value™ is €19.60, compared to a current price of €7.25 — trading 63% below its estimated fair value. The current Dividends per Share is €0.00. ImmunityBio's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For ImmunityBio (STU:26CA), the current Dividends per Share is €0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ImmunityBio (STU:26CA) Overvalued in 2026?

Based on GuruFocus' analysis, ImmunityBio stock appears to be undervalued. The current stock price of €7.25 is trading 63% below its estimated GF Value™ of €19.60. GuruFocus considers ImmunityBio to be Possible Value Trap.

Key valuation signals for STU:26CA:

  • Dividends per Share: €0.00
  • GF Value™: €19.60 vs. price of €7.25 (63% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the STU:26CA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ImmunityBio Business Description

Other Exchanges IBRX:USA
Address 3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
64GF Score

Get the complete analysis for STU:26CA

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.25
Price
€19.60
GF Value